Join to View Full Profile
1705 NE Pacific StreetBox 357710Seattle, WA 98107
Phone+1 206-221-2023
Dr. Cooper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a Clinical Assistant Professor in the Division of Hematology and Oncology at the University of Washington and serve as Assistant Medical Director for Inpatient Oncology Services at the University of Washington Medical Center and Fred Hutchinson Cancer Center. I have expertise in the management of patients with hematologic malignancies receiving transplantation, chemotherapy, and immune-based therapies, including cellular therapy. I also have an interest in classical hematology and in hematologic complications after solid organ transplantation, including graft-versus-host disease. I am board-certified in hematology, medical oncology, and internal medicine. Prior to pursuing a career in medicine, I had a 10-year career as a chemical engineer where my areas of expertise included pyrolysis, distillation, and adsorption processes.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2016 - 2019
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2013 - 2016
Texas Tech University Health Sciences Center School of MedicineClass of 2013, MD
Texas Tech University Health Sciences CenterPhD, Pharmacology, 2008 - 2011
Certifications & Licensure
WA State Medical License 2016 - 2027
MA State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsHyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.Lucas C Zarling, Philip A Stevenson, Lorinda A Soma, Christen H Martino, Mary-Elizabeth M Percival
European Journal of Haematology. 2023-12-01 - 5 citationsPhase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.Ryan D Cassaday, Lucas C Zarling, Kelsey-Leigh A Garcia, Olga Sala-Torra, Philip A Stevenson
Leukemia & Lymphoma. 2023-05-01 - 6 citationsHow I diagnose and treat acute graft-versus-host disease after solid organ transplantation.Jason P Cooper, Janis L Abkowitz
Blood. 2023-03-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
